From: Candidate genes for idiopathic epilepsy in four dog breeds
Gene Name | Designator | H | Chi Square P-Value | Results |
---|---|---|---|---|
*ARX | First Set | 0.396 | 0.606 | Not Significant |
*CACNA1A | First Set | 0.000 | (---) | Monomorphic |
*CACNA1A | Second Set | 0.408 | 0.740 | Not Significant |
CACNA1B | First Set | 0.370 | 0.905 | Not Significant |
CACNA1D | First Set | 0.699 | 0.529 | Not Significant |
CACNA1E | First Set | 0.675 | 0.953 | Not Significant |
CACNA1F | First Set | 0.106 | (---) | Low Heterozygosity |
CACNA1G | First Set | 0.000 | (---) | Monomorphic |
CACNA1G | Second Set | 0.023 | (---) | Low Heterozygosity |
*CACNA1H | First Set | 0.000 | (---) | Monomorphic |
*CACNA1H | Second Set | 0.517 | 0.272 | Not Significant |
CACNA1I | First Set | 0.483 | 0.449 | Not Significant |
#CACNA2D2 | First Set | 0.308 | 0.442 | Not Significant |
CACNB1 | First Set | 0.261 | (---) | Low Heterozygosity |
CACNB2 | First Set | 0.000 | (---) | Monomorphic |
CACNB3 | First Set | 0.322 | 0.718 | Not Significant |
*CACNB4 | First Set | 0.628 | 0.709 | Not Significant |
#CACNG2 | First Set | 0.690 | 0.382 | Not Significant |
CACNG3 | First Set | 0.000 | (---) | Monomorphic |
CACNG3 | Second Set | 0.591 | 0.527 | Not Significant |
CACNG4 | First Set | 0.298 | (---) | Low Heterozygosity |
CACNG6 | First Set | 0.482 | 0.323 | Not Significant |
CHRNA1 | First Set | 0.491 | 0.730 | Not Significant |
CHRNA1 | Second Set | 0.670 | 0.256 | Not Significant |
CHRNA1 | Third Set | 0.656 | 0.374 | Not Significant |
CHRNA1 | Fourth Set | 0.452 | 0.582 | Not Significant |
*CHRNA2 | First Set | 0.461 | 0.644 | Not Significant |
*CHRNA4 and KCNQ2 | See KCNQ2 | Â | Â | Â |
CHRNA5 | First Set | 0.389 | 0.483 | Not Significant |
CHRNA7 | First Set | 0.810 | 0.924 | Not Significant |
CHRNA9 | First Set | 0.615 | 0.875 | Not Significant |
CHRNB1 | First Set | 0.000 | (---) | Monomorphic |
*CHRNB2 | First Set | 0.333 | 0.055 | Not Significant |
*CLCN2 | First Set | 0.519 | 0.600 | Not Significant |
DNM1 | First Set | 0.139 | (---) | Low Heterozygosity |
DNM1 | Second Set | 0.364 | 0.799 | Not Significant |
DNM1 | Third Set | 0.500 | 0.834 | Not Significant |
DNM1 | Fourth Set | 0.000 | (---) | Monomorphic |
DNM1 | Fifth Set | 0.484 | 0.464 | Not Significant |
*GABRA1 | First Set | 0.549 | 0.354 | Not Significant |
*GABRD | First Set | 0.088 | (---) | Low Heterozygosity |
*GABRD | Second Set | 0.088 | (---) | Low Heterozygosity |
*GABRD | Third Set | 0.081 | (---) | Low Heterozygosity |
*GABRG2 | First Set | 0.219 | (---) | Low Heterozygosity |
*GABRG2 | Second Set | 0.458 | 0.929 | Not Significant |
*KCNA1 | First Set | 0.171 | (---) | Low Heterozygosity |
KCND2 | First Set | 0.480 | 0.036 | Inconclusive |
KCND2 | Second Set | 0.729 | 0.155 | Not Significant |
KCND2 | Third Set | 0.124 | (---) | Low Heterozygosity |
*KCNQ2 and CHRNA4 | First Set | 0.441 | 0.677 | Not Significant |
*KCNQ3 | First Set | 0.382 | 0.904 | Not Significant |
KCNQ5 | First Set | 0.100 | (---) | Low Heterozygosity |
*LGI1 | First Set | 0.440 | 0.244 | Not Significant |
*ME2 | First Set | 0.219 | (---) | Low Heterozygosity |
*NHLRC1 | Second Set | 0.405 | 0.240 | Not Significant |
*SCN1A | First Set | 0.749 | 0.706 | Not Significant |
*SCN1B | First Set | 0.000 | (---) | Monomorphic |
*SCN1B | Second Set | 0.000 | (---) | Monomorphic |
*SCN1B | Third Set | 0.026 | (---) | Low Heterozygosity |
*SCN1B | Fourth Set | 0.485 | 0.233 | Not Significant |
*SCN2A | First Set | 0.686 | 0.767 | Not Significant |
SCN3A | First Set | 0.000 | (---) | Monomorphic |
SCN3A | Second Set | 0.437 | 0.378 | Not Significant |
SCN3B | First Set | 0.000 | (---) | Monomorphic |
SCN3B | Second Set | 0.000 | (---) | Monomorphic |
SCN8A | First Set | 0.152 | (---) | Low Heterozygosity |
SCN8A | Second Set | 0.576 | 0.996 | Not Significant |
SCN11A | First Set | 0.597 | 0.967 | Not Significant |